Treatment of atopic dermatitis with the xenon chloride excimer laser

E. Baltás, Z. Csoma, L. Bodai, F. Ignácz, A. Dobozy, L. Kemény

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: Narrow-band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow-band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow-band ultraviolet B. Objective: The purpose of this study was to evaluate the therapeutic efficacy of the 308 nm excimer laser in atopic dermatitis. Patients and methods: Fifteen patients with atopic dermatitis (less than 20% body area involvement) were treated with a xenon chloride excimer laser (XTRAC laser, Photomedex Inc.) twice weekly. The severity of the atopic dermatitis was assessed via (i) a clinical score characterizing the intensity of erythema, infiltration, lichenification and excoriation; (ii) the quality of life, determined by means of a questionnaire; and (iii) a visual linear analogue scale, with which the patients scored the severity of their pruritus. Results: After 1 month of laser therapy, the clinical scores were significantly lower than the initial values. Similar decreases were observed for the quality of life and pruritus scores. No serious or unpleasant side-effects were bserved. Conclusion: These results suggest that the xenon chloride excimer laser is an effective and well-tolerated treatment for localized atopic dermatitis.

Original languageEnglish
Pages (from-to)657-660
Number of pages4
JournalJournal of the European Academy of Dermatology and Venereology
Volume20
Issue number6
DOIs
Publication statusPublished - Jul 2006

Fingerprint

Excimer Lasers
Atopic Dermatitis
Pruritus
Lasers
Quality of Life
Therapeutics
Phototherapy
Laser Therapy
Erythema
Ultraviolet Rays
Visual Analog Scale
Psoriasis

Keywords

  • Atopic dermatitis
  • Excimer laser
  • Phototherapy

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Treatment of atopic dermatitis with the xenon chloride excimer laser. / Baltás, E.; Csoma, Z.; Bodai, L.; Ignácz, F.; Dobozy, A.; Kemény, L.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 20, No. 6, 07.2006, p. 657-660.

Research output: Contribution to journalArticle

@article{30bd991fffc84ebfadc1e15d8c1149b3,
title = "Treatment of atopic dermatitis with the xenon chloride excimer laser",
abstract = "Background: Narrow-band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow-band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow-band ultraviolet B. Objective: The purpose of this study was to evaluate the therapeutic efficacy of the 308 nm excimer laser in atopic dermatitis. Patients and methods: Fifteen patients with atopic dermatitis (less than 20{\%} body area involvement) were treated with a xenon chloride excimer laser (XTRAC laser, Photomedex Inc.) twice weekly. The severity of the atopic dermatitis was assessed via (i) a clinical score characterizing the intensity of erythema, infiltration, lichenification and excoriation; (ii) the quality of life, determined by means of a questionnaire; and (iii) a visual linear analogue scale, with which the patients scored the severity of their pruritus. Results: After 1 month of laser therapy, the clinical scores were significantly lower than the initial values. Similar decreases were observed for the quality of life and pruritus scores. No serious or unpleasant side-effects were bserved. Conclusion: These results suggest that the xenon chloride excimer laser is an effective and well-tolerated treatment for localized atopic dermatitis.",
keywords = "Atopic dermatitis, Excimer laser, Phototherapy",
author = "E. Balt{\'a}s and Z. Csoma and L. Bodai and F. Ign{\'a}cz and A. Dobozy and L. Kem{\'e}ny",
year = "2006",
month = "7",
doi = "10.1111/j.1468-3083.2006.01495.x",
language = "English",
volume = "20",
pages = "657--660",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Treatment of atopic dermatitis with the xenon chloride excimer laser

AU - Baltás, E.

AU - Csoma, Z.

AU - Bodai, L.

AU - Ignácz, F.

AU - Dobozy, A.

AU - Kemény, L.

PY - 2006/7

Y1 - 2006/7

N2 - Background: Narrow-band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow-band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow-band ultraviolet B. Objective: The purpose of this study was to evaluate the therapeutic efficacy of the 308 nm excimer laser in atopic dermatitis. Patients and methods: Fifteen patients with atopic dermatitis (less than 20% body area involvement) were treated with a xenon chloride excimer laser (XTRAC laser, Photomedex Inc.) twice weekly. The severity of the atopic dermatitis was assessed via (i) a clinical score characterizing the intensity of erythema, infiltration, lichenification and excoriation; (ii) the quality of life, determined by means of a questionnaire; and (iii) a visual linear analogue scale, with which the patients scored the severity of their pruritus. Results: After 1 month of laser therapy, the clinical scores were significantly lower than the initial values. Similar decreases were observed for the quality of life and pruritus scores. No serious or unpleasant side-effects were bserved. Conclusion: These results suggest that the xenon chloride excimer laser is an effective and well-tolerated treatment for localized atopic dermatitis.

AB - Background: Narrow-band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow-band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow-band ultraviolet B. Objective: The purpose of this study was to evaluate the therapeutic efficacy of the 308 nm excimer laser in atopic dermatitis. Patients and methods: Fifteen patients with atopic dermatitis (less than 20% body area involvement) were treated with a xenon chloride excimer laser (XTRAC laser, Photomedex Inc.) twice weekly. The severity of the atopic dermatitis was assessed via (i) a clinical score characterizing the intensity of erythema, infiltration, lichenification and excoriation; (ii) the quality of life, determined by means of a questionnaire; and (iii) a visual linear analogue scale, with which the patients scored the severity of their pruritus. Results: After 1 month of laser therapy, the clinical scores were significantly lower than the initial values. Similar decreases were observed for the quality of life and pruritus scores. No serious or unpleasant side-effects were bserved. Conclusion: These results suggest that the xenon chloride excimer laser is an effective and well-tolerated treatment for localized atopic dermatitis.

KW - Atopic dermatitis

KW - Excimer laser

KW - Phototherapy

UR - http://www.scopus.com/inward/record.url?scp=33745285349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745285349&partnerID=8YFLogxK

U2 - 10.1111/j.1468-3083.2006.01495.x

DO - 10.1111/j.1468-3083.2006.01495.x

M3 - Article

C2 - 16836491

AN - SCOPUS:33745285349

VL - 20

SP - 657

EP - 660

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 6

ER -